Stay updated with breaking news from Aditxt. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aditxt, Inc. (NASDAQ:ADTX – Get Rating)’s stock price fell 7% on Tuesday . The stock traded as low as $0.83 and last traded at $0.85. 18,404 shares traded hands during trading, a decline of 88% from the average session volume of 151,277 shares. The stock had previously closed at $0.91. Aditxt Stock Performance The firm’s […]
20.09.2022 - Aditxt, Inc., (Nasdaq: ADTX) (the “Company” or “Aditxt”), a biotech innovation company developing and commercializing technologies focused on monitoring and modulating the immune system, today announced the closing of its previously announced public ...
08.07.2022 - Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the 'Company'), a biotech innovation company developing and commercializing technologies focused on monitoring and reprogramming the immune system, today announces that its therapeutic program Adimune, has ... Seite 1
Aditxt, Inc. (NASDAQ:ADTX – Get Rating) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 724,200 shares, an increase of 79.5% from the April 30th total of 403,500 shares. Based on an average daily volume of 595,800 shares, the short-interest […]
03.03.2022 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AiPharma Group Ltd. to Aditxt, Inc. (“the Company”) (NasdaqCM: ADTX). Under the terms of the ...